Correlation Between Telix Pharmaceuticals and Conico

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Telix Pharmaceuticals and Conico at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Telix Pharmaceuticals and Conico into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Telix Pharmaceuticals and Conico, you can compare the effects of market volatilities on Telix Pharmaceuticals and Conico and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Telix Pharmaceuticals with a short position of Conico. Check out your portfolio center. Please also check ongoing floating volatility patterns of Telix Pharmaceuticals and Conico.

Diversification Opportunities for Telix Pharmaceuticals and Conico

-0.44
  Correlation Coefficient

Very good diversification

The 3 months correlation between Telix and Conico is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Telix Pharmaceuticals and Conico in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Conico and Telix Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Telix Pharmaceuticals are associated (or correlated) with Conico. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Conico has no effect on the direction of Telix Pharmaceuticals i.e., Telix Pharmaceuticals and Conico go up and down completely randomly.

Pair Corralation between Telix Pharmaceuticals and Conico

Assuming the 90 days trading horizon Telix Pharmaceuticals is expected to generate 8.45 times less return on investment than Conico. But when comparing it to its historical volatility, Telix Pharmaceuticals is 9.07 times less risky than Conico. It trades about 0.1 of its potential returns per unit of risk. Conico is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  1.00  in Conico on September 19, 2024 and sell it today you would earn a total of  0.00  from holding Conico or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Telix Pharmaceuticals  vs.  Conico

 Performance 
       Timeline  
Telix Pharmaceuticals 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Telix Pharmaceuticals are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Telix Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
Conico 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Conico has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's forward-looking indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Telix Pharmaceuticals and Conico Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Telix Pharmaceuticals and Conico

The main advantage of trading using opposite Telix Pharmaceuticals and Conico positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Telix Pharmaceuticals position performs unexpectedly, Conico can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Conico will offset losses from the drop in Conico's long position.
The idea behind Telix Pharmaceuticals and Conico pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope